(Press-News.org) Los Angeles, CA – December 4, 2025 – Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.
Immunosenescence, the natural decline of the immune system with age, significantly reduces the effectiveness of cancer vaccines. Yet, despite its clinical importance, age-related immune decline is seldom incorporated into vaccine development pipelines. Current 2D culture systems are unable to capture these complex age-specific immune responses, thereby limiting their predictive value towards clinical translation.
To address this need, Dr. Vadim Jucaud’s research team at the Terasaki Institute developed a lymph node paracortex-inspired organ-on-a-chip platform that models key steps in cancer vaccine immune responses, which are characterized by antigen presentation, antigen-specific T cell activation, and downstream tumor-specific cytotoxicity. By comparing immune responses from young and older lymphocytes, the lymph node on-a-chip platform captures functional differences that naturally emerge with age.
Using this platform, the team demonstrated that young antigen-presenting cells displayed significantly stronger peptide presentation compared to old cells. This increased activity led to higher activation of antigen-specific T cells and enhanced cytotoxicity against cancer cells. Notably, these age-dependent differences were detectable only with the lymph node on-a-chip system, underscoring its ability to reveal biologically relevant immune variations that traditional 2D cultures cannot.
“This work introduces our lymph node on-a-chip platform for cancer vaccine testing,” said Dr. Vadim Jucaud, Principal Investigator and Assistant Professor at the Terasaki Institute. “Unlike traditional 2D models, this advanced system replicates age-related immune responses, which is critical because older adults face the highest cancer risk and often have diminished immunity. By accurately modeling these conditions in vitro, our platform enables more reliable insights into cancer vaccine performance, therefore accelerating development and improving outcomes.”
By more accurately reflecting the biology of aging, this novel platform offers a valuable tool for understanding how immunosenescence influences cancer vaccine efficacy. This technology may help guide the development of next-generation immunotherapies designed to meet the needs of older patients, ensuring that emerging cancer treatments support those who depend on them most.
A link to the publication can be found here: https://pubs.rsc.org/en/Content/ArticleLanding/2025/LC/D5LC00533G
A link to Dr. Vadim Jucaud’s lab page can be found here: https://terasaki.org/institute/research/investigators/vadim-jucaud-laboratory.html
For more information, please contact:
Vadim Jucaud, Ph.D.
Email: vjucaud@terasaki.org
About the Terasaki Institute for Biomedical Innovation
The Terasaki Institute for Biomedical Innovation is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. The Institute aims to enhance the quality of human life through translational research and the acceleration of biomedical innovation. TIBI's research focuses on the development of biomaterials, cellular and tissue engineering, medical devices, and microfluidic systems.
###
END
New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations
2025-12-04
ELSE PRESS RELEASES FROM THIS DATE:
No, we don't need more and more data about nature. We need more people to use the data
2025-12-04
Europe is gobbling up almost 50 square metres of land and topsoil per second. And Norway tops the list of European countries with the most land lost to construction per person, according to a study initiated by the Arena for Journalism in Europe and the Norwegian Broadcasting Corporation, NRK. At the same time, we have never had access to more data and knowledge about nature and the ecosystems we are building on.
"We are acquiring more and more ecological data as a basis for land-use planning. Then you would think that the decisions we make ...
Research explores effect of parental depression symptoms on children’s reward processing
2025-12-04
In newly published research, Binghamton University doctoral student Elana Israel, MS ’22, explores which depressive symptoms largely affect children’s neural responses to feedback.
Depression in parents can affect a child’s reward processing, or how their brains react to positive and negative feedback. Israel and Psychology Professor Brandon Gibb, director of the Mood Disorders Institute, explored whether a specific symptom of depression in parents known as anhedonia, a loss of interest or pleasure in things, may be specifically responsible for this link. The study will be included in ...
Phonetic or morpholexical issues? New study reveals L2 French ambiguity
2025-12-04
Ambiguous speech production is a common challenge for learners of a second language (L2), but identifying whether the problem lies in pronunciation or deeper linguistic processing is not always straightforward. A new study conducted by Professor Sylvain Detey from Waseda University, with Dr. Verdiana De Fino from IRIT, UT3, University of Toulouse & Archean Labs, France, and Dr. Lionel Fontan, Head of Archean Labs, France, sheds light on this distinction. Their study was published on October 30, 2025, in the journal Language Testing in Asia.
The researchers sought to determine whether ambiguous speech errors made by Japanese learners of French could be better categorized through a combined ...
Seeing inside smart gels: scientists capture dynamic behavior under stress
2025-12-04
Advances in materials science have led to the development of “smart materials,” whose properties do not remain static but change in response to external stimuli. One such material is poly(N-isopropylacrylamide), or PNIPAM, a polymer gel that alters its solubility with temperature. The polymer contains hydrophilic amide groups and hydrophobic isopropyl groups. At low temperatures, the amide groups form strong hydrogen bonds with water, keeping the material well-swollen and soluble. However, as the temperature increases, these hydrogen bonds weaken while ...
Korea University researchers create hydrogel platform for high-throughput extracellular vesicle isolation
2025-12-04
Extracellular vesicles (EVs) have rapidly emerged as one of the most promising frontiers in modern biology. These nano-sized messengers mediate communication between cells, tissues, and organs, influencing processes from immune signaling to cancer progression. Their growing diagnostic, prognostic, and therapeutic relevance has accelerated research worldwide. Yet one major limitation persists: the absence of efficient, scalable, and equipment-independent EV isolation methods. Existing techniques, including ultracentrifugation and size-exclusion chromatography (SEC), remain labor-intensive, instrumentation-heavy, and unsuitable for processing large-volume biofluids.
To ...
Pusan National University researchers identify the brain enzyme that drives nicotine addiction and smoking dependence
2025-12-04
Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that reinforce repeated use and make quitting extremely difficult. For decades, scientists have focused primarily on neurons to explain how these changes occur. But growing evidence suggests that other brain cells may play a far more active role in shaping addictive behavior than previously thought.
Building on this shift in understanding, a team of researchers led by Professor Eun Sang Choe from the Department of Biological Sciences, Pusan National ...
Pathway discovered to make the most common breast cancer tumor responsive to immunotherapy
2025-12-04
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer. This subtype accounts for 70% of breast cancer cases, and despite effective treatments, it causes the highest mortality in total cases. Additionally, immunotherapy is not effective or approved because it shows no immune system response in these tumors, ...
Air pollution linked to more severe heart disease
2025-12-04
CHICAGO – Long-term exposure to common air pollutants is associated with more advanced coronary artery disease—with notable differences between women and men—according to a large-scale study of more than 11,000 adults being presented today at the annual meeting of the Radiological Society of North America (RSNA).
The findings show that even levels of pollution below or near regulatory standards and typical urban exposures are associated with early signs of heart disease—often before symptoms appear—and underscore the importance of improving air quality to reduce cardiovascular ...
Where the elements come from
2025-12-04
Kyoto, Japan -- "Why are we here?" is humanity's most fundamental and persistent question. Tracing the origins of the elements is a direct attempt to answer this at its deepest level. We know many elements are created inside stars and supernovae, which then cast them out into the universe, yet the origins of some key elements has remained a mystery.
Chlorine and potassium, both odd-Z elements -- possessing an odd number of protons -- are essential to life and planet formation. According to current theoretical models, stars ...
From static papers to living models: turning limb development research into interactive science
2025-12-04
The choreographed movements that cells perform to form complex biological shapes, like our hands, have fascinated scientists for centuries. Now, researchers at EMBL Barcelona have launched LimbNET, an open-access online platform that allows scientists to directly choreograph this dance by computationally simulating how genes guide these intricate growth processes. Their work has recently been published in the journal Molecular Systems Biology.
LimbNET is much more than a simple data repository. It is a new type of platform allowing ...